Wallach, J; McCorvy, J; Halberstadt, A. Selective, partial, and arrestin-biased 5-HT2A agonists with utility in various disorders Patent WO 2022/241006 A1, 17 Nov 2022. 11.7 MB. #53
Wallach, J; Cao, AB; Calkins, MM; Heim, AJ; Lanham, JK; Bonniwell, EM; Hennessey, JJ; Bock, HA; Anderson, EI; Sherwood, AM; Morris, H; de Klein, R; Klein, AK; Cuccurazzu, B; Gamrat, J; Fannana, T; Zauhar, R; Halberstadt, AL; McCorvy, JD. Identification of 5-HT2A receptor signaling pathways responsible for psychedelic potential bioRxiv, 31 Jul 2023, 2023.07.29.551106. 9.8 MB. https://doi.org/10.1101/2023.07.29.551106 #25O-NB-3-I (34) LC,MS,NMR
Wallach, J; Cao, AB; Calkins, MM; Heim, AJ; Lanham, JK; Bonniwell, EM; Hennessey, JJ; Bock, HA; Anderson, EI; Sherwood, AM; Morris, H; de Klein, R; Klein, AK; Cuccurazzu, B; Gamrat, J; Fannana, T; Zauhar, R; Halberstadt, AL; McCorvy, JD. Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential Nat. Commun., 15 Dec 2023, 14 (1), 8221. 14.9 MB. https://doi.org/10.1038/s41467-023-44016-1 #34 MS,NMR
25I-NBOMe · 2C-I-NBOMe · N-(2-Methoxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine · INBMeO
25I-NBMeOH · N-(2-Hydroxymethylbenzyl)-4-iodo-2,5-dimethoxyphenethylamine
N-(2-Hydroxybenzyl)-4-iodo-2,5-dimethoxyamphetamine · DOI-NBOH
25I-NB3OMe · N-(3-Methoxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine
25I-NB4OMe · N-(4-Methoxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine